GAS5 and glioblastoma: Furthermore, GAS5 exhibits anti-oncogenic properties in GBM by modulating the IL-6/STAT3 pathway both in vitro and in vivo, leading to the inhibition of tumor growth in a xenograft model (Wu et al., 2022).